Human AP endonuclease 1 (APE1): From mechanistic insights to druggable target in cancerRachel Abbotts, Srinivasan Madhusudan|Cancer Treatment Reviews|2010Cited by 243
Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancerTarek M. Abdel-Fatah, Srinivasan Madhusudan, Roslin Russell et al.|Molecular Oncology|2014Cited by 151
Human apurinic/apyrimidinic endonuclease (APE1) is a prognostic factor in ovarian, gastro-oesophageal and pancreatico-biliary cancersAhmad Al‐Attar, Srinivasan Madhusudan, Lucy Gossage et al.|British Journal of Cancer|2010Cited by 111
Targeting XRCC1 Deficiency in Breast Cancer for Personalized TherapyRebeka Sultana, Srinivasan Madhusudan, Nada Albarakati et al.|Cancer Research|2012Cited by 101
Synthetic lethal targeting of DNA double‐strand break repair deficient cells by human apurinic/apyrimidinic endonuclease inhibitorsRebeka Sultana, Srinivasan Madhusudan, Daniel R. McNeill et al.|International Journal of Cancer|2012Cited by 94